Nothing Special   »   [go: up one dir, main page]

HALUSKA et al., 1990 - Google Patents

Uterine estrogen receptors are increased by RU486 in late pregnant rhesus macaques but not after spontaneous labor

HALUSKA et al., 1990

Document ID
17931220101757800123
Author
HALUSKA G
WEST N
NOVY M
BRENNER R
Publication year
Publication venue
The Journal of Clinical Endocrinology & Metabolism

External Links

Snippet

Progesterone withdrawal as a mechanism for parturition in primates is controversial. The progesterone antagonist RU486, given in late pregnancy to rhesus monkeys at a dose of 47 mmol/kg· day (20 mg/kg· day), causes an increase in uterine activity, but not the expected …
Continue reading at academic.oup.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

Similar Documents

Publication Publication Date Title
HALUSKA et al. Uterine estrogen receptors are increased by RU486 in late pregnant rhesus macaques but not after spontaneous labor
Khan-Dawood et al. Estrogen and progesterone receptor and hormone levels in human myometrium and placenta in term pregnancy
Jewelewicz Management of infertility resulting from anovulation
Swahn et al. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium
Ginsburg Luteal phase defect: Etiology, diagnosis, and management
Chwalisz et al. The progesterone antagonist onapristone increases the effectiveness of oxytocin to produce delivery without changing the myometrial oxytocin receptor concentrations
Batista et al. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy
Ghosh et al. Anti-nidatory effect of a single, early post-ovulatory administration of mifepristone (RU 486) in the rhesus monkey
Miller et al. Superovulatory doses of pregnant mare serum gonadotropin cause delayed implantation and infertility in immature rats
Von Hertzen et al. Research on new methods of emergency contraception
Ross Gonadotropins and preantral follicular maturation in women
Lantta et al. Progesterone and estradiol receptors in the cytosol of the human uterine artery
Mishell Jr et al. Termination of early gestation with the anti-progestin steroid RU 486: medium versus low dose
Critchley et al. Serum PP14 levels in a patient with Turner's syndrome pregnant after frozen embryo transfer
Cameron et al. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth
Miyake Progestational substances
FAYEZ et al. Virilization in pregnancy associated with polycystic ovary disease
Daels et al. Endogenous prostaglandin secretion during cloprostenol-induced abortion in mares
Majewska et al. Modulation of uterine GABAA receptors during gestation and by tetrahydroprogesterone
Willcox et al. Changes in total and free concentrations of steroid hormones in the plasma of women throughout pregnancy: effects of medroxyprogesterone acetate in the first trimester
Owiti et al. The effect of the anti-progestin RU 486 on early pregnancy in the long-tailed macaque (Macaca fascicularis)
Puri et al. Effects of progesterone antagonist ZK 98.299 on early pregnancy and foetal outcome in bonnet monkeys
Goncalves et al. Influence of an antiprogestin (onapristone) on in vivo and in vitro fertilization
GORODESKI et al. Myometrial oxytocin receptors levels in the pregnant rat are higher in distal than in proximal portions of the horn and correlate with disparate oxytocin responsive myometrial contractility in these segments
Zelinski-Wooten et al. A chronic, low-dose regimen of the antiprogestin ZK 137 316 prevents pregnancy in rhesus monkeys.